Peter Kirwan
Overview
Explore the profile of Peter Kirwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1950
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunn D, McCabe L, Ward D, Phillips A, Lampe F, Burns F, et al.
J Acquir Immune Defic Syndr
. 2025 Jan;
98(3):274-281.
PMID: 39813302
Background: The risk of onward HIV transmission is strongly influenced by the interval between HIV infection and its diagnosis. The SELPHI trial examined whether this interval could be reduced by...
2.
Hall V, Insalata F, Foulkes S, Kirwan P, Sparkes D, Atti A, et al.
J Infect
. 2023 Nov;
88(1):30-40.
PMID: 37926119
Third doses of COVID-19 vaccines were widely deployed following the primary vaccine course waning and the emergence of the Omicron-variant. We investigated protection from third-dose vaccines and previous infection against...
3.
Rodger A, McCabe L, Phillips A, Lampe F, Burns F, Ward D, et al.
Lancet HIV
. 2022 Dec;
9(12):e838-e847.
PMID: 36460023
Background: High levels of HIV testing in men who have sex with men remain key to reducing the incidence of HIV. We aimed to assess whether the offer of a...
4.
Pantazis C, Yang A, Lara E, McDonough J, Blauwendraat C, Peng L, et al.
Cell Stem Cell
. 2022 Dec;
29(12):1685-1702.e22.
PMID: 36459969
Human induced pluripotent stem cell (iPSC) lines are a powerful tool for studying development and disease, but the considerable phenotypic variation between lines makes it challenging to replicate key findings...
5.
Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, et al.
N Engl J Med
. 2022 Feb;
386(13):1207-1220.
PMID: 35172051
Background: The duration and effectiveness of immunity from infection with and vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are relevant to pandemic policy interventions, including the timing of...
6.
White H, Okhai H, Kirwan P, Rafeeq S, Dillon H, Hefford P, et al.
HIV Med
. 2021 Dec;
23(6):650-660.
PMID: 34939299
Introduction: People living with HIV (PLWH) are at high risk of active tuberculosis (TB) but this risk in the era of antiretroviral treatment (ART) remains unclear. It is critical to...
7.
Mitchell H, Thomson N, Jenkins C, Dallman T, Painset A, Kirwan P, et al.
Microbiol Spectr
. 2021 Dec;
9(3):e0121321.
PMID: 34908501
The public health value of whole genome sequencing (WGS) for spp. in England has been limited by a lack of information on sexual identity and behavior. We combined WGS data...
8.
Brown A, Croxford S, Nash S, Khawam J, Kirwan P, Kall M, et al.
HIV Med
. 2021 Sep;
23(1):90-102.
PMID: 34528739
Objectives: We describe COVID-19 mortality among people with and without HIV during the first wave of the pandemic in England. Methods: National surveillance data on adults (aged ≥ 15 years)...
9.
Brizzi F, Birrell P, Kirwan P, Ogaz D, Brown A, Delpech V, et al.
Lancet HIV
. 2021 Jun;
8(7):e440-e448.
PMID: 34118196
Background: To manage the HIV epidemic among men who have sex with men (MSM) in England, treatment as prevention strategies based on test and treat were strengthened between 2011 and...
10.
Allen H, Kirwan P, Brown A, Mohammed H, Hughes G, Marks M, et al.
Sex Transm Infect
. 2020 Nov;
97(3):221-225.
PMID: 33172915
Objective: A resurgence in bacterial STIs, notably syphilis, among gay, bisexual and other men who have sex with men (MSM) has been detected in England. A Canadian modelling study postulated...